The global “Non-Invasive Prenatal Testing market“ size is projected to reach USD 10.88 billion by the end of 2027. The presence of several large scale companies will have a positive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments, and Consumables & Reagents), Technology (Next Generation Sequencing, Microarray, PCR, and Rolling Circular Amplification), End User (Hospitals, and Clinical Laboratories) Regional Forecast, 2020-2027,” the market was worth USD 2.95 billion in 2019 and will exhibit a CAGR of 17.8% during the forecast period, 2020-2027.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/sample/non-invasive-prenatal-testing-market-100998
Non-Invasive Prenatal Testing (NIPT) are used to analyze cell-free fetal DNA that detects whether the fetus will be born with certain genetic abnormalities. This process analyzes small fragments of a DNA that circulate in the blood of a pregnant woman. NIPT is described as non-invasive as only the blood of the pregnant woman is studied and it possesses no risk to the fetus. The massive investments in the development of efficient NIPT tools will bode well for the growth of the overall NIPT market in the foreseeable future. The presence of several large scale companies operating in several countries across the world will have a huge impact on the growth of the overall market in the foreseeable future. The reducing costs of genetic testing will bode well for the growth of the NIPT market in the coming years.
An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
industry developments that will drive the market growth in the forthcoming years.
Covid-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers
The Covid-19 pandemic has had an adverse effect on several industries across the world. The efforts taken to curb the spread of the disease have had a damaging impact on several industries across the world. The rapidly rising cases of coronavirus across the world have urged healthcare professionals to focus on tools associated with the treatment of the disease and deviated attention from other concepts such as NIPT. As a result, the Covid-19 pandemic has had a minimal impact on the non-invasive prenatal market in the past few months.
For more information visit :
https://www.fortunebusinessinsights.com/industry-reports/non-invasive-prenatal-testing-market-100998
Increasing Number of Company Mergers and Acquisitions will have a Huge Impact on Market Growth
The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of company collaborations has made the highest impact on market growth. In March 2019, Natera announced that it has formed a strategic partnership with QIAGEN. Through this collaboration, the company will look to develop a breakthrough cell-free DNA assays. The companies will look to capitalize on QIAGEN’s GeneReader NGS System. Such collaborations are aimed at advancing in the NIPT sector and companies will look to maximize the use of technologically advanced concepts. Natera’s collaboration with QIAGEN is among the major company collaborations of recent times that have had a major say on the growth of the overall market.
North America to Emerge Dominant; Presence of Several Diagnostic Centres to Aid Growth
The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing penetration of non-invasive prenatal testing will bode well for the growth of the regional market. The increasing incidence of down syndrome among babies, especially in the United States will have a massive impact on the growth of the regional market. The increasing investments in the research and development of efficient NIPT by large scale companies in this region will emerge in favor of market growth. As of 2019, the market in North America was worth USD 1.52 billion and this value is projected to increase further in the coming years.
List of companies profiled in the report:
- Illumina, Inc. (U.S.)
- YOURGENE HEALTH (U.K.)
- Natera (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- PerkinElmer Inc. (U.S.)
- Laboratory Corporation of America (U.S.)
- Eurofins LifeCodexx GmbH (Germany)
- Others
Have Any Query? Ask Our Experts:
Global Non-Invasive Prenatal Testing Market Segmentation :
By Product
- Consumables & Reagents
- Instruments
By Technology
- NGS
- Microarray
- PCR
- Rolling Circular Amplification
By End User
- Hospitals
- Clinical Laboratories
By Geography
- North America
- By Product
- By Technology
- By End User
- By Country
DRIVING FACTORS
Increase in the Prevalence of Chromosomal Abnormalities to Augment the Demand for NIPT
Recently, the maternal age at childbearing has shifted because of a wide range of social and economic factors. According to a report published by the Office for National Statistics (ONS) in England, the average age of mothers in 2017 increased to 30.5 years, from 30.4 years in 2016. This has resulted in an increase in the prevalence of down syndrome and other genetic complications in newborns.
According to a report published by EUROCAT – Surveillance of Congenital Anomalies in Europe: epidemiology of Down syndrome in 2019, it was estimated in Europe annually approximately 104,000 babies were born with congenital anomalies, of which 8,320 babies were suffering from Down Syndrome. This has led to the early screening of pregnant women through prenatal tests including non-invasive ones.
Table Of Content :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Technological Advancements in Non-Invasive Prenatal Testing (NIPT) Techniques
- Number of NIPT Tests Performed, Key Regions, 2019
- Impact of COVID-19 on Non-Invasive Prenatal Testing Market
- Key Industry Developments – Mergers, Acquisitions, Etc.
Continue…
Related Reports:
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245